Endovia Health Sciences annual return on equity
2016
2022
2023
Endovia Health Sciences Return on Equity (ROE) Growth & History (EDVA)
Endovia Health Sciences's return on equity was −1,130.20% for fiscal 2023.
View full Endovia Health Sciences company overviewEndovia Health Sciences annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-12-31 | −1,130.20% | −891.79 pp |
| 2022 | 2022-12-31 | −238.42% | — |
| 2016 | 2016-12-31 | −255.85% | — |
Endovia Health Sciences quarterly return on equity
Q3.14
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q3.18
Q4.18
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q3.25
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q3 2025 | 2025-09-30 | −127.60% | — |
| Q3 2023 | 2023-09-30 | −342.38% | −294.42 pp |
| Q2 2023 | 2023-06-30 | −97.03% | −52.68 pp |
| Q1 2023 | 2023-03-31 | −44.09% | +7.18 pp |
| Q4 2022 | 2022-12-31 | −49.64% | +12.81 pp |
| Q3 2022 | 2022-09-30 | −47.96% | +58.09 pp |
| Q2 2022 | 2022-06-30 | −44.36% | +43.68 pp |
| Q1 2022 | 2022-03-31 | −51.27% | — |
| Q4 2021 | 2021-12-31 | −62.45% | — |
| Q3 2021 | 2021-09-30 | −106.05% | — |
| Q2 2021 | 2021-06-30 | −88.04% | — |
| Q4 2018 | 2018-12-31 | −315.63% | — |
| Q3 2018 | 2018-09-30 | −37.40% | −350.11 pp |
| Q3 2017 | 2017-09-30 | 312.71% | +368.05 pp |
| Q2 2017 | 2017-06-30 | −600.69% | −573.73 pp |
| Q1 2017 | 2017-03-31 | −236.24% | −277.11 pp |
| Q4 2016 | 2016-12-31 | −134.94% | — |
| Q3 2016 | 2016-09-30 | −55.34% | — |
| Q2 2016 | 2016-06-30 | −26.96% | — |
| Q1 2016 | 2016-03-31 | 40.87% | — |
| Q3 2014 | 2014-09-30 | −1,473.17% | — |
Endovia Health Sciences return on equity trends
Between the periods ended 2016-12-31 and 2023-12-31, Endovia Health Sciences's return on equity decreased from −255.85% to −1,130.20%, a change of −874.36 percentage points. The latest reported quarter, Q3 2025, shows −127.60%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Endovia Health Sciences source filings ↗